Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-001409
Filing Date
2023-07-14
Accepted
2023-07-14 13:04:31
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20230331.htm   iXBRL 10-Q 375769
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 7944
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4311
  Complete submission text file 0001096906-23-001409.txt   2343591

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20230331_cal.xml EX-101.CAL 17066
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20230331_def.xml EX-101.DEF 60440
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20230331_lab.xml EX-101.LAB 141414
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20230331_pre.xml EX-101.PRE 130099
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20230331.xsd EX-101.SCH 29432
48 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20230331_htm.xml XML 263732
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 231088618
SIC: 2833 Medicinal Chemicals & Botanical Products